Pulmonx (LUNG) Gains from Investment Securities (2019 - 2025)
Pulmonx (LUNG) reported Gains from Investment Securities of -$122000.0 for Q3 2025, down 206.09% year-over-year from $115000.0 in Q3 2024, and down 1120.0% quarter-over-quarter from -$10000.0 in Q2 2025.
Pulmonx (LUNG) Gains from Investment Securities (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Gains from Investment Securities data on file, last reported at -$122000.0 in Q3 2025.
- Gains from Investment Securities for Q3 2025 came in at -$122000.0, down 206.09% year-over-year; the trailing twelve-month figure through Sep 2025 was $744000.0 (up 362.9% YoY), and the FY2024 annual result was $556000.0, up 1444.44% from the prior year.
- Gains from Investment Securities slipped to -$122000.0 in Q3 2025 per LUNG's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $507000.0 in Q4 2024 and troughed at -$332000.0 in Q4 2023.
- A 5-year average of $63157.9 and a median of $5000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 11333.33% in 2022, then plunged 620.0% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $290000.0 in 2021, then tumbled by 199.31% to -$288000.0 in 2022, then slipped by 15.28% to -$332000.0 in 2023, then soared by 252.71% to $507000.0 in 2024, then slumped by 124.06% to -$122000.0 in 2025.
- Business Quant data shows LUNG's Gains from Investment Securities at -$122000.0 in Q3 2025, -$10000.0 in Q2 2025, and $369000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -122,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 201,000.00 |